Diseases (160)
Diagnostic Testing (75)

Note: Evaluate cardiovascular risk.

Note: Rule out hyperlipidemia.

Note: Patients with DM have an increased incidence of lipid abnormalities, creating risk for CVD

Note: Can be elevated in polycysitc ovarian syndrome (PCOS).

Note:

Note: Rule out atherosclerosis as a cause of disease.

Note: Lipid profiles may be deranged in a patient with ACS and lend little to the immediate diagnosis.

Note: Monitor lipids, cholesterol.

Note: Rule out hypercholesteremia.

Note: R/O pseudohyponatremia due to either elevated triglycerides or cholesterol.

Note: Smokers usually have lower high-density lipoprotein cholesterol. Intern Med 2006;45(18):1027.
Disease Management Testing (58)

Note:

Note: Patients with DM have an increased incidence of lipid abnormalities, creating risk for CVD

Note: Monitor for dyslipidemia in patients receiving cyclosporin, tacrolimus, sirolimus, everolimus or prednisone

Note: Patients should be screened annually for dyslipidemia after transplantation

Note: If elevated, to monitor therapy.

Note: Elevated LDL concentrations are common and may require therapy.

Note: Evaluate for hyperlipidemia in patients treated with second generation anti-psychotics
Other Supportive/Alternative Tests (4)

Note: Rule out cardiovascular disease related to increase levels of cholesterol.

Overview

The lipid profile, also known as the coronary risk panel, is comprised of total cholesterol, triglyceride, LDL-C (low density lipoprotein cholesterol), and HDL-C (high density lipoprotein cholesterol). It is usually used for evaluation of the risk for coronary heart disease and stroke. Testing lipid profile and especially cholesterol and cholesterol particles is the first step in screening for atherosclerosis risk, which might be the cause of heart attack and stroke. A heart attack or stroke is most commonly caused by blood vessels being blocked or by atherosclerosis (hardening of the arteries).

If through lipid testing it is discovered that a lipid disorder exists, treatments can be started to normalize lipid levels. Normalization can be achieved through medication, changes in diet, weight loss, and exercise. Therefore, this profile can be used as a screening test for risk evaluation for coronary heart disease and stroke, as well as diagnostic test for diagnosis and treatment monitoring of coronary heart disease, and familial hypercholesterolemia. It can be also used to monitor cholesterol and lipid-lowering lifestyle changes such as diet and exercise or to monitor cholesterol lowering drug therapy. Individuals with high blood pressure, tobacco smokers, individuals with a family history of cardiovascular disease, older people, and diabetes mellitus patients are at risk and should be screened. A more extended panel called NMR LipoProfile® test can be used for further screening and/or diagnosis. This test measures LDL particle number and size of LDL particles, as well as direct measurement of HDL and VLDL subclasses.

Cholesterol
Cholesterol is a steroid, a waxy substance that is found in the blood, tissues, and organs of all mammals including humans. Cholesterol is synthesized mainly in the liver. Metabolized cholesterol accounts for 75% of the cholesterol level, and diet accounts for the other 25%. Total cholesterol level in the body is dependent on many factors such as diet, liver function, lipid metabolism, heredity, and lifestyle choices. Testing serum cholesterol is the first step in screening for atherosclerosis risk.

Triglycerides
Triglycerides are stored in the fat cells of the body and serve as a main source of body energy. Triglycerides are absorbed in the intestine and are also synthesized in the liver. Elevated triglycerides are now considered an independent risk factor for coronary artery disease, and a major risk factor for acute pancreatitis, particularly when serum triglyceride levels are >1000 mg/dL.

High density lipoproteins (HDL)
HDL is responsible for the transport of cholesterol from the peripheral cells to the liver, where it is converted to bile acids which are excreted into the intestine via the biliary tract. Elevated HDL concentrations are protective against coronary heart disease, while reduced HDL concentrations indicate increased cardiovascular risk.

Low-density lipoprotein (LDL)
LDL belongs to a group of lipoproteins which serve as a transporter for cholesterol and lipids. Testing for LDL is used to evaluate the risk for coronary heart disease and stroke. High levels are associated with an increased risk of atherosclerosis and coronary heart disease and stroke.

Clinical Utility

  • Evaluate the risk for coronary heart disease
  • Diagnosis of Atherosclerosis (arteriosclerotic vascular disease)
  • Diagnosis of familial hypercholesterolemia
  • Used to evaluate the effectiveness of drug therapy (cholesterol lowering drugs)
  • As an aid in evaluation of diabetes mellitus, nephrotic syndrome, and liver disease with biliary obstruction
  • As an aid in evaluation of fatty liver in chronic alcoholism
  • As an aid in diagnosis of lipoproteinemia due to lipase deficiency
  • Monitoring drug treatment therapy

Interpretation

Increased in:

  • Coronary heart disease and stroke
  • Familial hypercholesterolemia
  • Familial combined hyperlipidemia
  • Atherosclerotic coronary artery disease
  • Hypertension
  • Hypothyroidism
  • Uncontrolled diabetes mellitus
  • Nephrotic syndrome
  • Liver disorders such as biliary obstruction and hepatocellular carcinoma
  • Cushing’s syndrome
  • Acute intermittent porphyria
  • Chronic alcoholism (fatty liver)
  • Biliary tract obstruction
  • Familial lipoprotein lipase deficiency
  • Familial dysbetalipoproteinemia
  • Obesity
  • Use of corticosteroids

Decreased in:

  • Severe liver disease (acute hepatitis, cirrhosis, malignancy)
  • Hyperthyroidism
  • Severe, acute, or chronic illness
  • Malnutrition and malabsorption
  • Extensive burns
  • Gaucher’s disease
  • Tangier disease (lipoprotein deficiency)
  • Hypolipoproteinemia and abetalipoproteinemia
  • Malnutrition
  • Decreased in use of some drugs such as: ascorbic acid, clofibrate, nicotinic acid, gemfibrozil

Reference Ranges

Total Cholesterol (mg/dL / mmol/L)
Category mg/dL mmol/L
Desirable <200 <5.2
Borderline High 200–239 5.2–6.2
High ≥240 ≥6.2

 

HDL Cholesterol (mg/dL / mmol/L)
Category mg/dL mmol/L
Low (Undesirable) <40 <1.04
Borderline 40–59 1.04–1.55
High (Desirable) >60 >1.55

 

LDL Cholesterol (mg/dL / mmol/L)
Category mg/dL mmol/L
Optimal <100 <2.6
Near / Above Optimal 100–129 2.6–3.3
Borderline High 130–159 3.4–4.1
High 160–189 4.1–4.9
Very High ≥190 ≥4.9

 

LDL / HDL Ratio Interpretation
Optimal <4.0
Borderline 4.0–5.0
High Risk >6.0

 

Triglycerides (mg/dL / mmol/L)
Category mg/dL mmol/L
Normal <150 <1.70
Borderline High 150–199 1.70–2.25
High 200–499 2.26–5.64
Very High ≥500 ≥5.65

Methodology
RIA (Radioimmunoassay), ELISA (Enzyme-Linked Immunosorbent Assay), RID (Radial ImmunoDiffusion), Enzymatic, Colorimetric methods to separate LDL, HDL and Triglycerides. Refer to individual laboratory methods.

Specimen Collection

Serum (SST).

Red top acceptable. 1 mL minimum. 12 hour fasting. No alcohol 24 hours prior to draw.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days

Additional Testing

Apolipoprotein A-I, Apolipoprotein B-100, C-reactive protein (CRP), Homocysteine, VLDL-C (very low density lipoprotein cholesterol), NMR Lipo profile, Liver panel, Comprehensive metabolic panel, CBC.

CPT
80061$13.39$13.39
82465$4.35$4.35
83718$8.19$8.19
83721$10.5$10.5
83722$34.19
84478$5.74$5.74

ICD10
  • AK - Alaska
  • AL - Alabama
  • AR - Arkansas
  • AS - American Samoa
  • AZ - Arizona
  • CA - California - Entire State
  • CO - Colorado
  • CT - Connecticut
  • DC - District of Columbia
  • DE - Delaware
  • FL - Florida
  • GA - Georgia
  • GU - Guam
  • HI - Hawaii
  • IA - Iowa
  • ID - Idaho
  • IL - Illinois
  • IN - Indiana
  • KS - Kansas
  • KY - Kentucky
  • LA - Louisiana
  • MA - Massachusetts
  • MD - Maryland
  • ME - Maine
  • MI - Michigan
  • MN - Minnesota
  • MO - Missouri - Entire State
  • MS - Mississippi
  • MT - Montana
  • NC - North Carolina
  • ND - North Dakota
  • NE - Nebraska
  • NH - New Hampshire
  • NJ - New Jersey
  • NM - New Mexico
  • NV - Nevada
  • NY - New York - Entire State
  • OH - Ohio
  • OK - Oklahoma
  • OR - Oregon
  • PA - Pennsylvania
  • PR - Puerto Rico
  • RI - Rhode Island
  • SC - South Carolina
  • SD - South Dakota
  • TN - Tennessee
  • TX - Texas
  • UT - Utah
  • VA - Virginia
  • VI - Virgin Islands
  • VT - Vermont
  • WA - Washington
  • WI - Wisconsin
  • WV - West Virginia
  • WY - Wyoming
  • CNMI - Northern Mariana Islands
  • EM - Missouri - Northeastern & Southern
  • WM - Missouri - Northwestern
  • DN - New York - Downstate
  • QN - New York - Queens
  • UN - New York - Upstate
  • NF - California - Northern
  • SF - California - Southern
Showing results for all states.
Filter:
ICD10 CODE AND DESCRIPTIONLCD CODENCD CODE
A15 - Respiratory tuberculosis
A15.0 - Tuberculosis of lung
A15.8 - Other respiratory tuberculosis
B15 - Acute hepatitis A
B16 - Acute hepatitis B
B16.1 - Acute hepatitis B with delta-agent without hepatic coma
B17 - Other acute viral hepatitis
B17.1 - Acute hepatitis C
B17.10 - Acute hepatitis C without hepatic coma
B17.2 - Acute hepatitis E
B18 - Chronic viral hepatitis
B18.0 - Chronic viral hepatitis B with delta-agent
B18.1 - Chronic viral hepatitis B without delta-agent
B18.2 - Chronic viral hepatitis C
B18.8 - Other chronic viral hepatitis
B18.9 - Chronic viral hepatitis, unspecified
B19 - Unspecified viral hepatitis
B19.0 - Unspecified viral hepatitis with hepatic coma
B19.1 - Unspecified viral hepatitis B
B19.10 - Unspecified viral hepatitis B without hepatic coma
B19.11 - Unspecified viral hepatitis B with hepatic coma
B19.2 - Unspecified viral hepatitis C
B19.20 - Unspecified viral hepatitis C without hepatic coma
B19.21 - Unspecified viral hepatitis C with hepatic coma
B19.9 - Unspecified viral hepatitis without hepatic coma
B20 - Human immunodeficiency virus [HIV] disease
B25.1 - Cytomegaloviral hepatitis
B25.2 - Cytomegaloviral pancreatitis
B26.81 - Mumps hepatitis
B37 - Candidiasis
B37.9 - Candidiasis, unspecified
B58.1 - Toxoplasma hepatitis
B59 - Pneumocystosis
B94.2 - Sequelae of viral hepatitis
B95 - Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere
B95.7 - Other staphylococcus as the cause of diseases classified elsewhere
B97.35 - Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
C22 - Malignant neoplasm of liver and intrahepatic bile ducts
C25 - Malignant neoplasm of pancreas
C46 - Kaposi's sarcoma
C46.9 - Kaposi's sarcoma, unspecified
C64 - Malignant neoplasm of kidney, except renal pelvis
C74 - Malignant neoplasm of adrenal gland
C74.0 - Malignant neoplasm of cortex of adrenal gland
C74.00 - Malignant neoplasm of cortex of unspecified adrenal gland
C74.01 - Malignant neoplasm of cortex of right adrenal gland
C74.02 - Malignant neoplasm of cortex of left adrenal gland
C74.1 - Malignant neoplasm of medulla of adrenal gland
C74.10 - Malignant neoplasm of medulla of unspecified adrenal gland
C74.11 - Malignant neoplasm of medulla of right adrenal gland

Additional ICD10
  • AK - Alaska
  • AL - Alabama
  • AR - Arkansas
  • AS - American Samoa
  • AZ - Arizona
  • CA - California - Entire State
  • CO - Colorado
  • CT - Connecticut
  • DC - District of Columbia
  • DE - Delaware
  • FL - Florida
  • GA - Georgia
  • GU - Guam
  • HI - Hawaii
  • IA - Iowa
  • ID - Idaho
  • IL - Illinois
  • IN - Indiana
  • KS - Kansas
  • KY - Kentucky
  • LA - Louisiana
  • MA - Massachusetts
  • MD - Maryland
  • ME - Maine
  • MI - Michigan
  • MN - Minnesota
  • MO - Missouri - Entire State
  • MS - Mississippi
  • MT - Montana
  • NC - North Carolina
  • ND - North Dakota
  • NE - Nebraska
  • NH - New Hampshire
  • NJ - New Jersey
  • NM - New Mexico
  • NV - Nevada
  • NY - New York - Entire State
  • OH - Ohio
  • OK - Oklahoma
  • OR - Oregon
  • PA - Pennsylvania
  • PR - Puerto Rico
  • RI - Rhode Island
  • SC - South Carolina
  • SD - South Dakota
  • TN - Tennessee
  • TX - Texas
  • UT - Utah
  • VA - Virginia
  • VI - Virgin Islands
  • VT - Vermont
  • WA - Washington
  • WI - Wisconsin
  • WV - West Virginia
  • WY - Wyoming
  • CNMI - Northern Mariana Islands
  • EM - Missouri - Northeastern & Southern
  • WM - Missouri - Northwestern
  • DN - New York - Downstate
  • QN - New York - Queens
  • UN - New York - Upstate
  • NF - California - Northern
  • SF - California - Southern
Showing results for all states.
Filter:
ICD10 CODE AND DESCRIPTIONLCD CODENCD CODE
A02.25 - Salmonella pyelonephritis
A06.4 - Amebic liver abscess
A15.0 - Tuberculosis of lung
A15.4 - Tuberculosis of intrathoracic lymph nodes
A15.5 - Tuberculosis of larynx, trachea and bronchus
A15.6 - Tuberculous pleurisy
A15.7 - Primary respiratory tuberculosis
A15.8 - Other respiratory tuberculosis
A15.9 - Respiratory tuberculosis unspecified
A36.81 - Diphtheritic cardiomyopathy
A51.44 - Secondary syphilitic nephritis
A51.45 - Secondary syphilitic hepatitis
A52.04 - Syphilitic cerebral arteritis
A52.74 - Syphilis of liver and other viscera
B00.81 - Herpesviral hepatitis
B15.0 - Hepatitis A with hepatic coma
B15.9 - Hepatitis A without hepatic coma
B16.0 - Acute hepatitis B with delta-agent with hepatic coma
B16.1 - Acute hepatitis B with delta-agent without hepatic coma
B16.2 - Acute hepatitis B without delta-agent with hepatic coma
B16.9 - Acute hepatitis B without delta-agent and without hepatic coma
B17.0 - Acute delta-(super) infection of hepatitis B carrier
B17.1 - Acute hepatitis C
B17.10 - Acute hepatitis C without hepatic coma
B17.11 - Acute hepatitis C with hepatic coma
B17.2 - Acute hepatitis E
B17.8 - Other specified acute viral hepatitis
B17.9 - Acute viral hepatitis, unspecified
B18.0 - Chronic viral hepatitis B with delta-agent
B18.1 - Chronic viral hepatitis B without delta-agent
B18.2 - Chronic viral hepatitis C
B18.8 - Other chronic viral hepatitis
B18.9 - Chronic viral hepatitis, unspecified
B19.0 - Unspecified viral hepatitis with hepatic coma
B19.1 - Unspecified viral hepatitis B
B19.10 - Unspecified viral hepatitis B without hepatic coma
B19.11 - Unspecified viral hepatitis B with hepatic coma
B19.2 - Unspecified viral hepatitis C
B19.20 - Unspecified viral hepatitis C without hepatic coma
B19.21 - Unspecified viral hepatitis C with hepatic coma
B19.9 - Unspecified viral hepatitis without hepatic coma
B25.1 - Cytomegaloviral hepatitis
B25.2 - Cytomegaloviral pancreatitis
B26.3 - Mumps pancreatitis
B26.81 - Mumps hepatitis
B26.83 - Mumps nephritis
B33.24 - Viral cardiomyopathy
B37.0 - Candidal stomatitis
B37.1 - Pulmonary candidiasis
B37.2 - Candidiasis of skin and nail

References

  • J Atheroscler Thromb. 2011 Nov 30. [PMID: 22129522]
  • Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):155-60. [PMID: 17206389]
  • JAMA. 2001 May 16;285(19):2486-97. [PMID: 11368702]
  • Compr Ther. 1996 Aug;22(8):492-500. [PMID: 8879916]
  • Geriatr Nurs. 2006 May-Jun;27(3):142-8. [PMID: 16757384]
  • J Am Acad Nurse Pract. 2003 Aug;15(8):350-60. [PMID: 14509100]
  • Mayo Clinic Proc. 2006;81:1225. [PMID: 16970219]
  • Med Gen Med. 2006;8:54. [PMID: 16915184]
  • Curr Atheroscler Rep. 2001 Sep;3(5):404-11. [PMID: 11565569]
  • Clin Chem Lab Med. 2000 Apr;38(4):287-300. [PMID: 10928647]
  • Endocrinol Metab Clin North Am. 2009 Mar;38(1):137-49. [PMID: 19217516]
  • Am J Med Sci. 2005;330:295. [PMID: 16355014]
  • Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier (2006). Pp. 351-356
  • Jacobs DS, DeMott WR, Oxley DK. Laboratory Test Handbook, fifth edition, Lexi-COMP, Inc (2004). Pp. 212-213.